Market Place
Sourcing Support
Tolmar Collaborates With UpScriptHealth For Oral Testosterone Access
23 Oct 2024 //
PR NEWSWIRE
The pharma& Group Partners With Tolmar to Promote Rubraca® for mCRPC
24 Sep 2024 //
PR NEWSWIRE
Enforcement Report - Week of October 4, 2023
04 Oct 2023 //
FDA
Tolmar`s Generic Paliperidone Palmitate Receives Approval in the U.S.
30 Jun 2023 //
FDA
Tolmar Announces Acquisition of JATENZO for the Treatment of Hypogonadism
27 Oct 2022 //
PRNEWSWIRE
Clarus Therapeutics Announces Completion of Auction for Sale of JATENZO
18 Oct 2022 //
GLOBENEWSWIRE
Enforcement Report - Week of August 10, 2022
10 Aug 2022 //
FDA
Enforcement Report - Week of December 22, 2021
22 Dec 2021 //
FDA
CMS Issues Permanent J-Code for Tolmar`s FENSOLVI Effective July 1, 2021
12 May 2021 //
PRNEWSWIRE
Tolmar Publishes Study in the February Issue of Journal of Urology on the Impact
13 Apr 2021 //
PRNESWIRE
Tolmar Publishes Study in the February Issue of Journal of Urology the Impact
13 Apr 2021 //
GLOBNEWSWIRE
Tolmar Affirms Supply of FENSOLVI® (leuprolide acetate) for Pediatric Patients
18 Aug 2020 //
PRNEWSWIRE
Tolmar Affirms Full Supply of Eligard® for Injectable Suspension Palliative
10 Aug 2020 //
PRNEWSWIRE
Real-World Data Analysis Published in the Journal of Urology- (LHRH) Dosing
18 May 2020 //
BUSINESSWIRE
Tolmar` Generic Azelaic Acid Receives Approval in US
21 Nov 2018 //
FDA
Tolmar’s Generic Adapalene: Benzoyl Peroxide Receives Approval In Us
26 May 2018 //
FDA
Tolmar’s Generic Azelaic Acid Receives Tentative Approval In Us
02 Sep 2017 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.